SHSE:603520 (China)
Â
Class A
Â¥
8.66
+0.22 (+2.61%)
Jul 31
Business Description
Zhejiang Starry Pharmaceutical Co Ltd
ISIN : CNE1000026N8
Share Class Description:
SHSE:603520: Class ATotal Employee Number:
1,905Compare
Compare
Traded in other countries / regions
603520.China Index Membership
SSE Composite Index IPO Date
2016-03-09Description
Zhejiang Starry Pharmaceutical Co Ltd is engaged in R&D, manufacture and marketing of active ingredient and intermediate X-CT non-ionic contrast agent series and Fluoroquinolones series.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.1 | |||||
Equity-to-Asset | 0.41 | |||||
Debt-to-Equity | 1.15 | |||||
Debt-to-EBITDA | 32.17 | |||||
Interest Coverage | 2.09 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.15 | |||||
Beneish M-Score | -2.35 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -8.2 | |||||
3-Year EBITDA Growth Rate | 5.5 | |||||
3-Year FCF Growth Rate | 31.2 | |||||
3-Year Book Growth Rate | 4.3 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 245.16 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 8.84 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 52.6 | |||||
9-Day RSI | 44.81 | |||||
14-Day RSI | 42.56 | |||||
3-1 Month Momentum % | -8.61 | |||||
6-1 Month Momentum % | 4.05 | |||||
12-1 Month Momentum % | -3.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.02 | |||||
Quick Ratio | 0.53 | |||||
Cash Ratio | 0.13 | |||||
Days Inventory | 207.04 | |||||
Days Sales Outstanding | 76.12 | |||||
Days Payable | 82.19 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 3.46 | |||||
Dividend Payout Ratio | 1.55 | |||||
3-Year Dividend Growth Rate | -33.1 | |||||
Forward Dividend Yield % | 3.46 | |||||
5-Year Yield-on-Cost % | 1.19 | |||||
3-Year Average Share Buyback Ratio | -8.5 | |||||
Shareholder Yield % | 1.15 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 21.83 | |||||
Operating Margin % | 6.25 | |||||
Net Margin % | 0.68 | |||||
EBITDA Margin % | 3.73 | |||||
FCF Margin % | -16.16 | |||||
OCF Margin % | -6.21 | |||||
ROE % | 0.65 | |||||
ROA % | 0.28 | |||||
ROIC % | 2.46 | |||||
3-Year ROIIC % | -5.98 | |||||
ROC (Joel Greenblatt) % | 2.25 | |||||
ROCE % | 2.52 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 180.42 | |||||
Forward PE Ratio | 29.86 | |||||
PE Ratio without NRI | 89.28 | |||||
Shiller PE Ratio | 28.83 | |||||
PS Ratio | 1.45 | |||||
PB Ratio | 1.47 | |||||
Price-to-Tangible-Book | 2.02 | |||||
EV-to-EBIT | 70.06 | |||||
EV-to-EBITDA | 70.06 | |||||
EV-to-Revenue | 2.62 | |||||
EV-to-FCF | -16.19 | |||||
Price-to-GF-Value | 0.79 | |||||
Price-to-Projected-FCF | 24.06 | |||||
Price-to-Median-PS-Value | 0.37 | |||||
Price-to-Graham-Number | 2.83 | |||||
Earnings Yield (Greenblatt) % | 1.43 | |||||
FCF Yield % | -10.52 | |||||
Forward Rate of Return (Yacktman) % | 5.67 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zhejiang Starry Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 2,471.145 | ||
| EPS (TTM) (Â¥) | 0.048 | ||
| Beta | 1.37 | ||
| 3-Year Sharpe Ratio | -0.26 | ||
| 3-Year Sortino Ratio | -0.35 | ||
| Volatility % | 36.96 | ||
| 14-Day RSI | 42.56 | ||
| 14-Day ATR (Â¥) | 0.444333 | ||
| 20-Day SMA (Â¥) | 9.0065 | ||
| 12-1 Month Momentum % | -3.5 | ||
| 52-Week Range (Â¥) | 7.89 - 14.37 | ||
| Shares Outstanding (Mil) | 438.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zhejiang Starry Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zhejiang Starry Pharmaceutical Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.250000 Cash Dividend | 2026-06-04 | 10.01 (-0.79%) | ||
| CNY 0.050000 Cash Dividend | 2025-09-12 | 11.90 (-1.33%) | ||
| CNY 0.100000 Cash Dividend | 2025-06-06 | 10.58 (-1.03%) | ||
| CNY 0.050000 Cash Dividend | 2024-09-09 | 8.22 (-2.49%) | ||
| 1.4:1 Stock Split | 2022-06-17 | 30.48 (-1.43%) | ||
| 1.4:1 Stock Split | 2020-06-01 | 44.88 (+9.57%) | ||
| 1.4:1 Stock Split | 2019-06-25 | 12.41 (+4.22%) |
Show
Entries
Zhejiang Starry Pharmaceutical Co Ltd Frequently Asked Questions
What is Zhejiang Starry Pharmaceutical Co Ltd(SHSE:603520)'s stock price today?
The current price of SHSE:603520 is ¥8.66. The 52 week high of SHSE:603520 is ¥14.37 and 52 week low is ¥7.89.
When is next earnings date of Zhejiang Starry Pharmaceutical Co Ltd(SHSE:603520)?
The next earnings date of Zhejiang Starry Pharmaceutical Co Ltd(SHSE:603520) is .
Does Zhejiang Starry Pharmaceutical Co Ltd(SHSE:603520) pay dividends? If so, how much?
The Dividend Yield %  of Zhejiang Starry Pharmaceutical Co Ltd(SHSE:603520) is 3.46% (As of Today), Highest Dividend Payout Ratio of Zhejiang Starry Pharmaceutical Co Ltd(SHSE:603520) was 15. The lowest was 0.21. And the median was 0.46. The  Forward Dividend Yield % of Zhejiang Starry Pharmaceutical Co Ltd(SHSE:603520) is 3.46%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Zhejiang Starry Pharmaceutical Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers